Pegasus Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-52,360
Closed -$4.08M 154
2017
Q2
$4.08M Buy
52,360
+25,995
+99% +$1.96M 1.08% 15
2017
Q1
$2.15M Sell
26,365
-1,627
-6% -$128K 0.89% 29
2016
Q4
$2.02M Buy
27,992
+2,215
+9% +$160K 0.89% 32
2016
Q3
$2M Sell
25,777
-4,223
-14% -$341K 0.95% 30
2016
Q2
$2.34M Buy
30,000
+195
+0.7% +$15.5K 1.21% 25
2016
Q1
$2.44M Sell
29,805
-2,350
-7% -$191K 1.32% 22
2015
Q4
$2.87M Sell
32,155
-155
-0.5% -$13.2K 1.44% 20
2015
Q3
$2.48M Sell
32,310
-54,383
-63% -$4.54M 1.41% 22
2015
Q2
$7.25M Buy
+86,693
New +$7.65M 3.2% 8

Other funds holding CAH

Pegasus Partners's CAH Position: Q3 2017 in Review

Pegasus Partners sold out of Cardinal Health (CAH) in Q3 2017, closing a stake of 52,360 shares — an estimated $4.08M sold.

Pegasus Partners first reported a position in CAH in Q2 2015 and held it in 9 quarters. The position peaked at $7.25M in Q2 2015. 712 funds tracked by Wall St. Rank hold CAH as of Q3 2017.

  • Pegasus Partners reported no remaining Cardinal Health position as of Q3 2017 after selling out during the quarter.
  • Pegasus Partners sold 52,360 Cardinal Health shares in Q3 2017, an estimated $4.08M.
  • Pegasus Partners first reported a position in Cardinal Health in Q2 2015 and held it in 9 quarters.
  • Pegasus Partners's Cardinal Health position peaked at $7.25M in Q2 2015.
  • 712 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2017.

Based on Pegasus Partners's 13F filing for Q3 2017, filed 9 Nov 2017.